Valproate, bipolar disorder and polycystic ovarian syndrome.
about
Special considerations in the treatment of patients with bipolar disorder and medical co-morbiditiesPharmacological treatment of bipolar disorder among children and adolescents.Psychotropic-induced weight gain and potential pharmacologic treatment strategies.Polycystic ovary syndrome in women using valproate: a review.Women and bipolar disorder across the life spanCurrent issues: women and bipolar disorder.Clear indications of emotion depend on vivid stimuli.Women are not the same as men: specific clinical issues for female patients with bipolar disorder.Bipolar disorder in women: reproductive events and treatment considerations.Metabolism, lifestyle and bipolar affective disorder.Women and epilepsy: review and practical recommendations.Maintenance treatment in bipolar disorder: a focus on aripiprazole.Associations between psychiatric disorders and menstrual cycle characteristics.Lithium chloride treatment induces epithelial cell proliferation in xenografted human endometriumEpigenetics of endometriosis.Sex-specific differences in side effects of psychotropic drugs: genes or gender?Evaluation of reproductive function in women treated for bipolar disorder compared to healthy controls.Obesity and mental illness: implications for cognitive functioning.Sex differences in rates of obesity in bipolar disorder: postulated mechanisms.Valproic acid as a therapy for adenomyosis: a comparative case series.The antiepileptic effect of sodium valproate during different phases of the estrous cycle in PTZ-induced seizures in rats.Reproductive function and risk for PCOS in women treated for bipolar disorder.Divalproex sodium for pediatric mixed mania: a 6-month prospective trial.Deterioration of metabolic parameters during short-term psychiatric inpatient treatment: a prospective naturalistic study.Clinical characteristics and management of bipolar disorder in women across the life span.Polycystic Ovary Syndrome in Bipolar Affective Disorder: A Hospital-based Study.
P2860
Q24806762-48DCE14E-6BBB-49A6-9633-A8C25AA45A39Q34158663-4D3943B7-921E-4311-841B-2E2333CA1924Q34418639-9BE3572E-BCDB-408F-BADF-F0F2469A3561Q34881401-55F0F223-1589-4530-BAAC-082CC947CEB9Q35022930-52980306-A910-40A4-9DF2-0DAB5DFA28BFQ35236993-174F1FE5-51D8-4886-A011-987D903D2D85Q35478174-23322E1A-05C6-4B1E-B019-D02733FE1441Q36068766-709A7A62-8BC8-4EF7-B80D-443A3322AFE2Q36181505-725E0ADF-167B-4E9A-871D-ADF844EE9B38Q36310319-68F587DD-A131-4892-83E6-63F28F58BE01Q36752925-4BA705D6-DDE5-4070-84FB-19DF5772085FQ36902005-27EE5E72-9758-4645-A484-61D3D37732A2Q36986442-F8A430B5-B95C-4042-9AFA-7F2005D956F5Q37260863-723A87C3-8464-45E0-A02F-7DE223F5BB89Q37571067-1277B95A-8EDC-4E32-9892-669E34CF82DBQ37598900-3DA8A8D7-D9ED-4301-8F16-2FCCC74E46E6Q37625064-70E76F8C-E2F3-4794-8DC4-A275A024FFA0Q38120446-CFE35F14-069E-4569-8DC7-FB1A95506D1CQ38182163-5D764D5C-FC82-49A1-A952-0223941278ABQ42986696-CC69000D-CBA9-42CE-A617-BF43E07342B1Q45085798-59266F23-9670-416A-9E8B-E93099AE313CQ46494852-4571D891-91E7-4529-9D4F-DCDC797C3054Q46494857-FA309545-63A9-4A34-8279-20BB151E50F5Q50778364-7ACDF4CE-B386-4710-9FB3-B23E106EF8DFQ51834824-8CB533B9-387D-477A-917D-E3880D564151Q55383932-4839887E-0183-4DE4-964D-AE5BFA21EDF6
P2860
Valproate, bipolar disorder and polycystic ovarian syndrome.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Valproate, bipolar disorder and polycystic ovarian syndrome.
@en
Valproate, bipolar disorder and polycystic ovarian syndrome.
@nl
type
label
Valproate, bipolar disorder and polycystic ovarian syndrome.
@en
Valproate, bipolar disorder and polycystic ovarian syndrome.
@nl
prefLabel
Valproate, bipolar disorder and polycystic ovarian syndrome.
@en
Valproate, bipolar disorder and polycystic ovarian syndrome.
@nl
P2093
P2860
P1433
P1476
Valproate, bipolar disorder and polycystic ovarian syndrome.
@en
P2093
Deborah A Mancini
Janaki Srinivasan
Roger S McIntyre
Sidney H Kennedy
Sonia McCann
P2860
P356
10.1034/J.1399-5618.2003.00009.X
P577
2003-02-01T00:00:00Z